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The molecular mechanism of autophagy and its
relationship to other lysosomal degradation path-
ways remain incompletely understood. Here, we
identified a previously uncharacterized mamma-
lian-specific protein, Beclin 2, which, like Beclin 1,
functions in autophagy and interacts with class III
PI3K complex components and Bcl-2. However,
Beclin 2, but not Beclin 1, functions in an addi-
tional lysosomal degradation pathway. Beclin 2 is
required for ligand-induced endolysosomal degra-
dation of several G protein-coupled receptors
(GPCRs) through its interaction with GASP1. Beclin
2 homozygous knockout mice have decreased em-
bryonic viability, and heterozygous knockout mice
have defective autophagy, increased levels of brain
cannabinoid 1 receptor, elevated food intake, and
obesity and insulin resistance. Our findings identify
Beclin 2 as a converging regulator of autophagy
and GPCR turnover and highlight the functional
and mechanistic diversity of Beclin family mem-
bers in autophagy, endolysosomal trafficking, and
metabolism.INTRODUCTION
Autophagy is a lysosomal degradation pathway that functions
in nutrient recycling, energy generation, and the clearance of
damaged proteins and organelles (Mizushima and Komatsu,
2011). This homeostatic pathway is conserved in all eukaryotes,
and orthologs of a core set of essential genes, the autophagy-
related (Atg) genes, have been discovered in organisms ranging
from yeasts to humans (Chen and Klionsky, 2011). During the
evolution of higher eukaryotes, many autophagy genes (such
as Atg8 and Atg1) have been duplicated, but the functional
importance of such duplication is not fully understood. In theory,
the duplicated genes may carry out new functions that convey
temporal-spatial specificity in multicellular organisms, fine-tune
autophagic activity at different levels, and/or mediate cross-
talk between autophagy and other biological pathways. The
increased complexity in the autophagy machinery in higher
eukaryotes may enhance the ability of such organisms to
respond and adapt to complex environmental signals.
It is possible that autophagy gene duplication evolved in part
to permit the integration of different lysosomal degradation
pathways. In addition to autophagy (which targets intracellular
components for degradation), cargos from extracellular sources
(such as plasma-membrane proteins that cycle through endo-
cytic vesicles and bacteria and apoptotic corpses that are
captured by phagocytosis) can be transported to lysosomesCell 154, 1085–1099, August 29, 2013 ª2013 Elsevier Inc. 1085
for degradation. Several autophagy proteins (such as Beclin 1,
Atg5, Atg7, and LC3) function in phagocytosis and apoptotic
corpse clearance (Levine et al., 2011), and components of the
Beclin 1/class III phosphatidylinositol 3-kinase (PI3K) autophagy
complex regulate endocytic degradation of the epidermal
growth factor receptor (EGFR) tyrosine kinase (Funderburk
et al., 2010). In addition to the role of autophagy proteins in
targeting cargo from different sources to the lysosome, there is
also overlap between the autophagy machinery and proteins
involved in other endosomal sorting pathways; for example,
the yeast genes VPS15, VPS34, and ATG6/VPS30 (the yeast
ortholog of mammalian beclin 1) are required for both autophagy
and efficient endosome-to-Golgi retrograde transport (Funder-
burk et al., 2010).
The lysosomal degradation of G protein-coupled receptors
(GPCRs), the largest family of cell-surface receptors encoded
in the human genome, represents a key mechanism for control-
ling cellular responses to environmental cues (Hanyaloglu and
von Zastrow, 2008). Following ligand-induced activation, inter-
nalized GPCRsmay undergo different fates that produce distinct
effects on cellular signaling, including endocytic sorting to a
recycling pathway that results in rapid signal resensitization or
endocytic sorting to the lysosome that results in permanent
signal termination. The best studied mechanism for postendo-
cytic sorting of GPCRs to the lysosome involves the ESCRT
(endosomal sorting complex required for transport) machinery
(Hurley and Emr, 2006), which mediates the targeting of ubiqui-
tinated cargo to the yeast vacuole/mammalian lysosome via
an endocytic intermediate compartment called the multivesic-
ular body. There is also evidence that non-ESCRT proteins
contribute to GPCR sorting to mammalian lysosomes. One fam-
ily of such proteins are the GPCR-associated sorting proteins,
GASP1 and GASP2, that associate with a broad range of seven
transmembrane-spanning GPCRs (Moser et al., 2010). GASP1
has been shown to regulate the degradation of several GPCRs
that traffic to lysosomes after agonist-induced endocytosis,
including the delta opioid receptor (DOR), cannabinoid 1 recep-
tor (CB1R), dopamine D2 receptor, bradykinin 1 receptor, and a
nonrecycling mutant of the b-adrenergic receptor (b-ala).
Despite the overlap between the autophagy machinery and pro-
teins involved in vacuolar protein sorting and in certain lysosomal
degradation pathways, it is not yet known whether any auto-
phagy proteins participate in agonist-induced lysosomal degra-
dation of GPCRs.
Here, we characterize a new autophagy gene homolog,
beclin 2, which also functions in ligand-induced degradation of
GASP1-regulated GPCRs. These findings identify a hitherto
unappreciated level of integration between two distinct lyso-
somal degradation pathways that exert crucial roles in eukary-
otic biology.
RESULTS
Identification of Beclin 2, a Beclin Family Member
Involved in Autophagy
Based upon a BLAST search of the human and mouse
databases, we identified novel mammalian-specific genes
NG_022940 and NG_028451, which encode a predicted 4311086 Cell 154, 1085–1099, August 29, 2013 ª2013 Elsevier Inc.amino acid, 49 kDa human protein and a predicted 447 amino
acid, 50 kDa mouse protein that share 57% and 44% sequence
identity (human andmouse, respectively) with the essential auto-
phagy and tumor-suppressor protein Beclin 1 (Figure 1A). Similar
to Beclin 1, the predicted proteins encoded by NG_022940 and
NG_028451 contain a BH3 domain, a central coiled-coil domain,
and a C-terminal evolutionarily conserved domain. Based on this
similarity in sequence and domain organization, we concluded
that NG_022940 and NG_028451 represent novel members of
the Beclin family and, therefore, named NG_022940 human
Beclin 2 and NG_028451 mouse Beclin 2.
Beclin 2 subfamily members are mammalian specific; Beclin 1
subfamily members are present in more primitive vertebrates
(such as fish) (Figure 1A); and, at least based on multiple
sequence alignments, Atg6/Beclin orthologs in invertebrate
organisms (such as S. cerevisiae, C. elegans, D. melanogaster,
A. thaliana) cannot be classified as either Beclin 1 or Beclin 2
(Figure S1 available online and data not shown). Although there
is a high level of amino acid sequence similarity between
mammalian Beclin 1 and Beclin 2, the genomic organizations
of beclin 1 and beclin 2 are quite different. Mouse and human
beclin 1 have 12 exons, whereas mouse beclin 2 contains only
one intron, and the human counterpart is intronless. Human
beclin 2 maps to chromosome 1q43 near the autophagy gene
MAP1LC3C, and the genomic location of mouse beclin 2
(chromosome 1 H4) is syntenic to that of human beclin 2.
We analyzed levels of mouse and human messenger RNA
(mRNA) and protein expression in selected tissues. We detected
mouse beclin 2 mRNA expression in multiple organs including
brain, skeletal muscle, placenta, thymus, and uterus and more
weakly in liver, testis, stomach, and 17-day-old embryos (Fig-
ure 1B). We also detected human Beclin 2 protein expression
(predicted molecular weight 49 kDa; apparent molecular weight
53 kDa) in samples from human fetal and adult brains using an
antibody generated against amino acids 49–67 of humanBeclin 2
(Figure 1C). We confirmed the specificity of this antibody by
showing that small interfering RNA (siRNA) directed against
human beclin 2 decreased protein expression of human Beclin 2,
but not humanBeclin 1 inHeLa cells (Figure 2A) andHEK293cells
(Figure S3). The detection of mouse beclin 2 mRNA and human
Beclin 2 protein expression provides biological evidence that
the database classification of NG_022940 and NG_028451 as
pseudogenes is incorrect.
The Beclin family member Beclin 1, an ortholog of yeast Atg6,
is required for mammalian autophagy (Chen and Klionsky, 2011).
To determine whether Beclin 2 also functions in autophagy, we
evaluated the effects of an siRNA that specifically targets Beclin
2 (Figures 2A and S2A) on basal and starvation-induced auto-
phagy in HeLa cells using three well-established assays (Mizush-
ima et al., 2010): degradation of p62, an autophagy substrate;
detection of GFP-LC3 puncta (autophagosomes); and conver-
sion of the nonlipidated form of LC3 (LC3-I) to the phosphatidyl-
ethanolamine-conjugated form (LC3-II). Although many studies
measure autophagy by examining LC3-II conversion, it should
be noted that several autophagy proteins, including yeast Atg6
and mammalian Beclin 1, are not required for LC3 lipidation
but are required for autophagosome formation (Mizushima
et al., 2010).
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Figure 1. Sequence Alignment and Expression Pattern of Beclin 2
(A) Alignment of Beclin 2 and Beclin 1 sequences. Shown are all knownBeclin 2 sequences, Beclin 1 sequences from selectedmammalian organisms possessing
Beclin 2, and Beclin 1 sequences from nonmammalian vertebrates whose genomes apparently encode only Beclin 1. See also Figure S1.
(B) RT-PCR analysis of mouse beclin 2 expression level in different tissues using cDNA from a pool of approximately 200 mice.
(C) Western blot detection of human Beclin 2 in fetal and adult human brain lysates.Duringnormal growth conditions,beclin 2 siRNAknockdown in
HeLa cells decreased numbers of GFP-LC3 puncta, decreased
the ratio of LC3-II/LC3-I, and increased the total levels of LC3
(which is also a substrate of autophagy), although no significant
changes were observed in p62 levels (Figures 2B–2D and S2B).
In response to amino acid starvation, both beclin 1 and beclin 2
siRNA knockdown resulted in decreased numbers of GFP-LC3
puncta, decreased conversion of LC3-I to LC3-II, and decreased
p62degradation (Figures 2B–2DandS2B). The decrease in auto-
phagosomes in basal and starvation conditionswas not due to anacceleration of autophagolysosomal maturation, as the num-
ber of autophagosomes was also decreased in beclin 1 and
beclin 2 siRNA-treated cells in the presence of the lysosomal
inhibitor bafilomycin A1 (Figure 2D). Furthermore, changes in
p62 or LC3 protein levels could not be attributed to indirect
effects of the siRNAs on p62 or LC3 mRNA expression (Fig-
ure S2C). The effect of beclin 2 (but not beclin 1) siRNA on basal
and starvation-induced autophagy (as measured by numbers of
GFP-LC3 puncta) was partially rescued by expression of a Beclin
2 siRNA nontargetable mutant rescue plasmid (Figures 2A, 2E,Cell 154, 1085–1099, August 29, 2013 ª2013 Elsevier Inc. 1087
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and S2A). The Beclin 2 siRNA nontargetable mutant plasmid also
rescued starvation-induced autophagy in beclin 2 knockdown
cells as measured by p62 degradation and LC3-II conversion
(Figure 2F). This suggests that the defect in autophagy is likely
due to depletion of Beclin 2, rather than an off-target effect of
beclin 2 siRNA. Taken together, these data indicate that Beclin 2,
like Beclin 1, functions in autophagy in human cells. Depending
on the sensitivity of the assay, the effect can be observed in basal
conditions aswell as in starvation conditions. In addition, beclin 2
siRNA blocked CCCP-induced Parkin-mediated mitophagy in
HeLa cells (Figure S2D), indicating a role for Beclin 2 in selective
autophagy.
Beclin 2 Interacts with Several Known Binding Partners
of Beclin 1
We examined whether mouse and human Beclin 2 interact with
known binding partners of Beclin 1 (Chen and Klionsky, 2011).
Several components of the class III PI3K complex, including
endogenous ATG14, AMBRA1, and VPS34 (which function in
autophagosome formation) and UVRAG (which functions in
autophagosome maturation) immunoprecipitated with Flag
epitope-tagged human Beclin 1, human Beclin 2, and mouse
Beclin 2 (Figure 2G). The coimmunoprecipitation of AMBRA1
was significantly stronger with human or mouse Beclin 2 than
with human Beclin 1. The Beclin 1-binding antiautophagy protein
Bcl-2 coimmunoprecipitated with Flag epitope-tagged mouse
and human Beclin 2 (Figure 2H); however, unlike with Beclin 1
(Pattingre et al., 2005), this interaction was not disrupted by star-
vation. No interaction was detected between mouse or human
Beclin2and theBeclin 1-bindingnegative regulatorof autophagy,
Rubicon. Thus, Beclin 2 interactswith several of the knownBeclin
1-binding partners, including ATG14, VPS34, AMBRA1, UVRAG,
and Bcl-2. However, Beclin 1 and Beclin 2 differ somewhat with
respect to binding affinities and/or regulation of certain protein-
protein interactions with other autophagy-related proteins.
GASP1 Interacts with Beclin 2
The alignment of Beclin 2 with Beclin 1 (Figure 1A) revealed
greater divergence at the N terminus as compared to the C ter-Figure 2. Beclin 2 Functions in Autophagy and Interacts with Known B
(A) Western blot detection of Beclin 1 and Beclin 2 in HeLa cells transfected with i
plasmid.
(B) Western blot detection of p62 and LC3 in HeLa cells transfected with indicated
and serum starvation (starvation ‘‘+’’). See Figure S2B for quantitative analysis o
(C) Representative images of GFP-LC3 puncta in HeLa/GFP-LC3 cells transfect
Arrow, representative autophagosome. Scale bar, 20 mm.
(D) Quantification of GFP-LC3 puncta in HeLa/GFP-LC3 cells transfected with i
cultured for 3 hr in normal or starvation medium.
(E) Quantification of GFP-LC3 puncta in HeLa/GFP-LC3 cells cotransfected wi
starvation medium.
(F) Western blot detection of p62 in HeLa cells cotransfected with indicated siRN
Quantification of relative levels of p62/actin, LC3-II/LC3-I, and total LC3/actin is
(G) Coimmunoprecipitation of class III PI3K complex components with indicated
using an anti-Flag antibody.
(H) Coimmunoprecipitation of Bcl-2 with indicated Beclin proteins in HeLa cells tr
nutrient-rich conditions or after 3 hr of starvation.
For (D) and (E), bars represent mean represent mean ± standard error of the me
observed in three independent experiments. *p < 0.05; **p < 0.01; ***p < 0.001; N
NC, nonsilencing control; WCL, whole-cell lysate. See also Figure S2.minus. This suggested that the N terminus of Beclin 2 might have
a unique, autophagy-independent function. To identify unique
interacting partners and functions of Beclin 2, we used the
N-terminal 88 amino acids of human Beclin 2 as bait and per-
formed a yeast two-hybrid screen of a human brain complemen-
tary DNA (cDNA) library. Fourteen hits were isolated thatmapped
to the C terminus of a 230 kDa protein, G protein-coupled recep-
tor-associated sorting protein 1 (GASP1) (Figure 3A), which is
required for agonist-induced lysosomal degradation of a subset
of GPCRs, including the DOR, the CB1R, and a nonrecycling
mutant form of the b-adrenergic (b-Ala) receptor (Martini et al.,
2007; Moser et al., 2010; Tappe-Theodor et al., 2007; Whistler
et al., 2002). The N-terminal domain of Beclin 1 (amino acids
1–90) did not interact with any of the Beclin 2-interacting
GASP1 fragments in a yeast two-hybrid interaction assay (data
not shown).
We confirmed that GASP1 interacts with Beclin 2 in mamma-
lian cells. Endogenous human GASP1 coimmunoprecipitated
with Flag epitope-tagged human Beclin 2, but not human
Beclin 1, in HEK293 cells (Figure 3B). Similarly, endogenous
mouse GASP1 coimmunoprecipitated strongly with Flag
epitope-tagged mouse Beclin 2, but only weakly with Beclin 1,
in mouse Neuro2A cells (Figure 3C). The interaction between
Beclin 2 and GASP1 is species specific, as no interaction
between human GASP1 and mouse Beclin 2 was detectable,
and the interaction between mouse GASP1 and human Beclin 2
was barely detectable (Figures 3B and 3C). The interaction is
specific for GASP1 and not other related family members, as
GASP2 did not coimmunoprecipitate with Beclin 2 (Figure 5A).
We also confirmed that endogenous GASP1 interacts with
endogenous Beclin 2 but not endogenous Beclin 1 in coimmuno-
precipitation experiments in HEK293 cells (Figures 3D and S3).
Consistent with the yeast two-hybrid screen results, Beclin 2
coimmunoprecipitated with a C-terminal fragment (amino acids
899–1395) of GASP1 (Figure 3E). Taken together, these data
demonstrate that GASP1 is a unique interaction partner of Beclin
2, but not of Beclin 1, and that this interaction is mediated
through the N-terminal region of Beclin 2 and the C-terminal
region of GASP1.eclin 1-Binding Partners
ndicated siRNA. Beclin 2 NTm, an siRNA nontargetable mutant Beclin 2 rescue
siRNA during growth in normal medium (starvation ‘‘-’’) or after 3 hr amino acid
f western blots from three independent experiments.
ed with indicated siRNA and cultured for 3 hr in normal or starvation medium.
ndicated siRNA, treated with 100 nM bafilomycin A1 or vehicle (DMSO), and
th indicated siRNA and indicated plasmid and cultured for 3 hr in normal or
A and indicated plasmid and cultured for 3 hr in normal or starvation medium.
shown below each gel lane.
Beclin proteins in HeLa cells transfected with indicated Flag-Beclin plasmids
ansfected with indicated Flag-Beclin constructs using an anti-Flag antibody in
an (SEM) of triplicate samples (50 cells per sample), and similar results were
S, not significant; ANOVA with Dunnett method.
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Figure 3. GASP1 Is an Interaction Partner of
Beclin 2
(A) Schematic depicting hits (14 colonies encoding
proteins mapping to indicated amino acids of
GASP1) isolated from yeast two-hybrid screen of
human brain cDNA library using N-terminal human
Beclin 2 (amino acids 1–88) as bait.
(B) Coimmunoprecipitation of endogenous human
GASP1 with human Flag-Beclin 2 in HEK293 cells
transfected with indicated plasmids.
(C) Coimmunoprecipitation of endogenous mouse
GASP1 with mouse Flag-Beclin 2 in mouse Neu-
ro2A cells transfected with indicated plasmids.
(D) Coimmunoprecipitation of endogenousGASP1
with endogenous Beclin 2 in HEK293 cells. Aster-
isks denote nonspecific bands.
(E) Coimmunoprecipitation of Flag-human Beclin 2
with Myc-tagged C-terminal human GASP1 in
HeLa cells transfected with indicated plasmids.
cGASP1, C-terminal GASP1. See also Figure S3.Beclin 2 Is Required for the Endolysosomal Trafficking
and Degradation of GPCRs
As Beclin 2, but not Beclin 1, interacts with GASP1, we hypoth-
esized that Beclin 2 may selectively function in the endolysoso-
mal trafficking and degradation of GPCRs that are regulated by
their C-terminal interactions with GASP1. To test this hypothesis,
we used the biotin protection degradation assay (Whistler et al.,
2002) to measure the degradation of GPCRs that are degraded
by postendosomal sorting to the lysosome (Figure S4A) in the
presence of different autophagy gene siRNAs or cGASP overex-
pression (Figure S4B).
First, we used the DOR as a marker substrate (Figures 4A and
4B). In HEK293 cells that stably express Flag-DOR, after 30 min
of DADLE ([D-Ala2, D-Leu5]-Enkephalin) agonist treatment, the
biotinylated receptors are internalized and protected frommem-
brane stripping and can be detected by the presence of biotin
signal in cell lysates immunoprecipitated by anti-Flag antibody.
After longer agonist treatment (180min), the endocytosed recep-
tors are transported to the lysosome, where they are degraded;
thus, the levels of detectable biotinylated receptors after1090 Cell 154, 1085–1099, August 29, 2013 ª2013 Elsevier Inc.membrane stripping are minimal. This
receptor degradation is dependent on
lysosomal function, as it is blocked in
cells treated with the lysosomal inhibitor
bafilomycin A1 (Figure S4C). The pattern
of lysosomal degradation of biotinylated
DORwas similar in cells treated with non-
silencing control siRNA as in cells treated
with beclin 1 siRNA, ATG14 siRNA,
and VPS34 siRNA, indicating that the
Beclin 1/VPS34/ATG14 complex (which
is involved in autophagy) is not involved
in GPCR degradation. In contrast, beclin
2 siRNA treatment resulted in the reten-
tion of biotinylated intracellular DOR after
prolonged agonist treatment (180 min),
suggesting that Beclin 2 is required forthe endolysosomal trafficking and degradation of certain
GPCRs. This block in DOR degradation with beclin 2 siRNA
treatment is similar to that observed with overexpression of
C-terminal GASP1, a dominant-negative form of GASP1 (Whis-
tler et al., 2002). In addition to DOR, we found that degradation
of two other GASP1-associated GPCRs, CB1R (Figure 4C) and
b-Ala (Figure 4D), were dependent on Beclin 2. Beclin 2 siRNA,
but not beclin 1 siRNA, increased levels of biotin-protected
internalized CB1R and b-Ala receptors at 180 min as robustly
as cGASP1 overexpression.
We confirmed the role of Beclin 2 in the postendosomal sorting
of DOR to the lysosome by fluorescent microscopy (Figure 4E).
By pulse-labeling cell-surface DOR with antibody, we found
that beclin 2, but not beclin 1, siRNA treatment resulted in the
trapping of internalized DORs in EEA1-positive endosomal struc-
tures and their failure to be transported to LAMP1-positive lyso-
somes after 60 min of agonist treatment.
Together, our results indicate that Beclin 2 is essential for
agonist-induced lysosomal turnover of several GASP1-interact-
ing GPCRs, including the DOR, CB1R, and b-Ala receptor, and
that Beclin 2 and Beclin 1 do not functionally overlap in GPCR
degradation. Moreover, the role of Beclin 2 in endolysosomal
trafficking may be limited to GASP1-dependent GPCRs; beclin 2
siRNA had no effect on agonist-induced lysosomal degradation
of another GPCR that is not regulated by GASP1, the chemokine
receptor CXCR4, or a receptor tyrosine kinase, PDGFR (Figures
S4D–S4F).
The signaling function of many GPCRs is regulated by posten-
dosomal sorting to lysosomes and degradation (Hanyaloglu and
von Zastrow, 2008). After agonist withdrawal and/or antagonist
treatment, some types of internalized GPCRs are recycled
back to the plasmamembrane and resensitized, whereas others,
such as several GASP1-associated GPCRs, are sorted to lyso-
somes for degradation and signaling downregulation. To test
whether loss of Beclin 2 leads to the recycling and resensitization
of GPCRs, we analyzed antagonist-induced receptor recycling
after beclin 2 siRNA treatment. Using either the biotin protection
degradation assay or pulse-chase experiments of antibody-
labeled cell-surface DOR detected by fluorescent microscopy,
we found that the agonist-induced internalized DOR in beclin 2
siRNA-treated cells recycled to the cell surface within 30 min
after antagonist treatment (Figures 4F and 4G). Thus, the
absence of Beclin 2-dependent lysosomal degradation of
internalized GPCRs allows their recycling back to the plasma
membrane.
The Beclin 2-GASP1 Interaction Is Required for GPCR
Degradation but Not for Autophagy
As Beclin 2 interacts with GASP1 and is required for the degra-
dation of GASP1-dependent GPCRs, we hypothesized that it
may function in GPCR degradation through a mechanism
involving its interaction with GASP1. To evaluate this hypothesis,
we sought to identify a single amino acid mutation in Beclin 2
that blocks binding to GASP1. First, we tested whether amino
acids 69–88 (predicted to be important based on secondary
structure) of Beclin 2 were required for GASP1 binding and found
that GASP1 failed to coimmunoprecipitate with a mutant of
Beclin 2 lacking these amino acids (Figure 5A). Next, to identify
point mutations within this region that might block GASP1 bind-
ing to Beclin 2, we made substitution mutations within amino
acids 69–88, focusing on residues that are conserved in ortho-
logs of Beclin 2 (which binds to GASP1) but not in orthologs of
Beclin 1 (which does not bind to GASP1) (Figure 5B). An isoleu-
cine to serine mutation at amino acid 80 (Beclin 2 I80S) blocked
GASP1 coimmunoprecipitation with Beclin 2 (Figure 5C),
whereas substitutions at neighboring positions (D70R, K75A,
and H77A) had no effect on the Beclin 2-GASP1 interaction.
Thus, I80 is essential for the Beclin 2-GASP1 interaction, and
the replacement of Beclin 2 isoleucine with a serine located in
the identical position in Beclin 1 disrupts the Beclin 2-GASP1
interaction.
We used the Beclin 2 I80S mutant to investigate whether the
Beclin 2-GASP1 interaction is necessary for Beclin 2 to function
in GPCR degradation and in autophagy. We analyzed DOR
degradation by using the biotin protection assay in HEK293 cells
transfected with beclin 2 siRNA and three different beclin 2
siRNA-resistant rescue plasmids that restore Beclin 2 expres-
sion in beclin 2 knockdown cells (Figure 5D), including oneencoding wild-type (WT) Beclin 2, one encoding Beclin 2 I80S,
and one encoding Beclin 2D69–88. The WT Beclin 2 rescue
plasmid reversed the effect of beclin 2 knockdown on GPCR
degradation, whereas the non-GASP1-interacting Beclin 2
I80S and Beclin 2D69–88 rescue plasmids had no effect (Figures
5E and 5F). In contrast, both WT Beclin 2 as well as non-GASP1-
interacting mutants of Beclin 2 (Beclin 2 I80S and Beclin
2D69–88) rescued starvation-induced autophagy in beclin 2
knockdown HeLa cells (Figures 5G and 5H). In addition, overex-
pression of the dominant-negative C-terminal GASP1 did not
block starvation-induced autophagy (Figure S5). Our results indi-
cate that GASP1 and the Beclin 2-GASP1 interaction are essen-
tial for agonist-induced GPCR degradation but are dispensable
for autophagy, and that autophagy and GPCR degradation are
two separate pathways that converge on Beclin 2.
Deficiencies in Autophagy and GPCR Degradation
in Beclin 2 Knockout Mice
To study the in vivo functions of Beclin 2, we generated targeted
mutant mice with a null mutation in beclin 2 (Figures S6A and
S6B). Embryonic and postnatal survival rates of beclin 2 homo-
zygous knockout mice were markedly lower than predicted by
Mendelian ratios (4% [4/117]) (Figure 6A). We confirmed the
loss of Beclin 2 protein expression in mouse embryonic fibro-
blasts (MEFs) and brain tissues of beclin 2 knockout mice (Fig-
ures 6B and S6C). In primary MEFs derived from beclin 2+/+,
beclin 2+/, and beclin 2/ littermates (Figure 6B), there was
less starvation-induced p62 degradation, decreased ratios of
LC3-II to LC3-I in basal and starvation conditions, and increased
levels of total LC3 in basal and starvation conditions in beclin
2-deficient MEFs compared with WT controls (Figures 6C and
S6D). By quantitative electron microscopic analysis, no geno-
type-specific differences in basal autophagy were detected
(although a trend toward decreased autophagy was observed
in beclin 2/ MEFs) (Figures 6D and 6E). During starvation,
both beclin 2+/ and beclin 2/ MEFs had fewer autophagic
structures (autophagosomes and autolysosomes) than WT
beclin 2+/+ MEFs. Beclin 2/ MEFs, but not beclin 2+/ MEFs,
showed a decrease in long-lived protein degradation during
basal conditions as compared to beclin 2+/+ MEFs, whereas
long-lived protein degradation was decreased during starvation
conditions in both beclin 2+/ and beclin 2/ MEFs (Figure 6F).
(The magnitude of this decrease was small; biallelic deletion of
beclin 2 had a similar, not greater, effect than monoallelic dele-
tion of beclin 1; Figure S6E.) In addition, the brains of beclin
2+/mice had elevated levels of total LC3, decreased conversion
of LC3-I to LC3-II, and increased p62 accumulation as compared
with the brains of WT littermates (Figure S6F). Together, these
data suggest that beclin 2 gene deletion impairs, but does not
completely abrogate, basal and starvation-induced autophagy.
Of note, we observed higher steady-state levels of CB1R in
beclin 2+/ and beclin 2/MEFs than inWT controls (Figure 6G).
We also detected higher levels of CB1R expression in brain
lysates of beclin 2+/ mice as compared to WT beclin 2+/+ litter-
mates (Figure 6H). In contrast, no increase in CB1R expression
was detected in the brains of beclin 1+/ mice as compared to
their WT littermates, suggesting that this increase was not due
to a defect in Beclin family member-dependent autophagy.Cell 154, 1085–1099, August 29, 2013 ª2013 Elsevier Inc. 1091
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Rather, these data are consistent with our siRNA knockdown
data in cultured cells indicating that Beclin 2, but not Beclin 1,
is involved in GASP1-dependent GPCR degradation. In further
support of this conclusion, the brains of beclin 2+/ mice had
increased levels of the dopamine 2 receptor (another GPCR
regulated by GASP1) but no difference in levels of the mu opioid
receptor, which does not bind GASP1 (Figure S6G).
Thus, our data in beclin 2/ MEFs and beclin 2+/ mice
demonstrate that Beclin 2 functions in two distinct lysosomal
degradation pathways, autophagy and the endolysomal traf-
ficking and degradation of certain GPCRs.
Beclin 2 Heterozygous Knockout Mice Develop Obesity
and Insulin Resistance
In mice, excess CB1R signaling increases food intake, results in
weight gain, and promotes diabetes/insulin resistance (Maccar-
rone et al., 2010), whereas pharmacological antagonism of
CB1R or genetic deletion of CB1R has the opposite effects on
food intake, weight, and insulin resistance (Di Marzo, 2008).
Therefore, we sought to examine whether beclin 2 heterozygous
mice develop obesity and/or insulin resistance. We fed 8-week-
old beclin 2+/ mice or WT littermates either regular diet (RD) or
high-fat diet (HFD) for 8 weeks and measured body weight, food
intake, and insulin sensitivity. Beclin 2+/ mice gained more
weight (Figure 7A) and had more food intake (Figure 7B) than
WT mice in either condition, despite comparable spontaneous
physical activity (Figures S7A and S7B), suggesting that their
increased body weight is likely caused by increased energy
intake rather than decreased energy expenditure. Furthermore,
compared to WT littermates, beclin 2+/ mice demonstrated
impaired glucose tolerance (Figures 7C and 7D, left graphs)
and decreased insulin sensitivity (Figures 7C and 7D, right
graphs) in RD and HFD conditions (see also Figures S7C–S7E).
None of these differences were observed in mice with monoal-
lelic loss of beclin 1 (Figures S7F–S7I). Thus, beclin 2 exerts a
unique role in metabolic regulation that is not shared by beclin 1.
To investigate whether CB1R accumulation contributes to the
diabetic phenotype in beclin 2+/mice, we evaluated the effects
of treatment with the CB1R antagonist rimonabant (Di Marzo,
2008) on glucose tolerance in mice fed a regular diet. As pre-Figure 4. Beclin 2 Is Required for Degradation of a Subset of GPCRs
(A, C, andD) Effects of indicated siRNA or cGASP1 overexpression on biotin-medi
cells stably expressing Flag-DOR, (C) the CB1R after agonist treatment (WN 55
receptor after agonist treatment (isoproterenol, 5 mM) in HEK293 cells stably exp
biotinylated GPCR prior to cell-surface biotin stripping; the second lane (strip) rep
lane (NT) represents the level of internalized biotinylated receptor with vehicle tre
internalized biotinylated receptor with agonist treatment for 30 min or 180 min
precipitated with anti-Flag antibody, analyzed by SDS-PAGE, and detected with
(B) Quantification of the ratio of DOR levels at 180 min versus 30 min in each
experiments. ***p < 0.001; NS, not significant; ANOVA with Dunnett method.
(E) Fluorescent microscopic imaging of DOR in HEK293 cells stably expressing F
treated with the agonist for 30 or 60 min, immunostained with anti-EEA1 or anti-L
Green, Flag-DOR; red, EEA1 or LAMP1. Scale bar, 10 mm.
(F) Effects of indicated siRNA on DOR recycling to the cell surface. HEK293/Flag-
treated with agonist for 140 min, antagonist for 30 min, and then subjected to st
(G) Immunofluorescence analysis of effects of indicated siRNA on fate of cell-s
antibody and then treated as in (F) (except without membrane stripping). Subcellul
bar, 10 mm.
See also Figure S4.dicted, body weight decreased in both WT and beclin 2+/
mice in response to rimonanbant given for 2 weeks (Figure 7E).
However, rimonabant did not affect glucose tolerance curves
in WT mice but decreased the glucose intolerance observed in
beclin 2+/mice (Figures 7F and S7J). This suggests that glucose
intolerance in beclin 2+/mice may be partly caused by a failure
in CB1R downregulation. Taken together, our data in beclin 2+/
mice are consistent with a role of Beclin 2-dependent degrada-
tion of CB1R in glucose homeostasis.
DISCUSSION
Our results demonstrate that Beclin 2 is an Atg6/Beclin family
member that functions in two different lysosomal degradation
pathways that are essential for cellular homeostasis, autophagy,
and the downregulation of certain seven-transmembrane-span-
ning GPCRs. The function of Beclin 2 in agonist-induced GPCR
lysosomal degradation is genetically distinct from that in auto-
phagy. It does not involve Beclin 1 or other Beclin 1/2-interacting
proteins such as ATG14 and VPS34 that function in autophagy.
In addition, starvation-induced autophagy, but not agonist-
induced GPCR degradation, can be rescued in beclin 2 knock-
down cells by a Beclin 2 mutant that cannot interact with
GASP1. The function of Beclin 2 in agonist-induced lysosomal
degradation is also likely distinct from other autophagy-indepen-
dent trafficking functions previously described for yeast Atg6/
Vps30 or mammalian Beclin 1, such as vacuolar protein sorting
and EGFR degradation (Funderburk et al., 2010). These func-
tions involve the Atg6/Beclin 1-interacting class III PI3K VPS34,
whereas we did not observe a role for human VPS34 in the
degradation of GASP1-dependent GPCRs. Thus, Beclin 2 exerts
an autophagy-independent and class III PI3K-independent
function in the endolysosomal trafficking and degradation of
GASP1-regulated GPCRs.
The dual, but mechanistically nonoverlapping, functions of
Beclin 2 in autophagy and GPCR degradation raise many ques-
tions. In terms of autophagy, it is unclear why a second ‘‘Beclin’’
is needed. The intronless nature of human Beclin 2, differential
pattern of tissue expression, and differential interaction pattern
of Beclin 2 versus Beclin 1 with certain autophagy regulatoryated protection of (A) the DOR after agonist treatment (DADLE, 5 mM) in HEK293
,212-1 mM) in HEK293 cells stably expressing Flag-CB1R, and (D) the b-Ala
ressing Flag-b-Ala. For (A), (C), and (D), the first lane (100%) represents total
resents the remaining biotinylated GPCR after cell-surface stripping; the third
atment after stripping; the fourth and fifth lanes (30’, 180’) represent levels of
, respectively, after stripping. Biotinylated Flag epitope-tagged GPCRs were
streptavidin overlay.
condition shown in (A). Bars represent mean ± SEM of three independent
lag-DOR treated with indicated siRNAs. Cells were fed with anti-Flag antibody,
AMP1 primary antibodies, and labeled with fluorescent secondary antibodies.
DOR cells were treated with agonist for 30 min or 180 min as in (A) or, in lane 6,
ripping of cell-surface biotin.
urface-labeled Flag-DOR. HEK293/Flag-DOR were incubated with anti-Flag
ar localization of Flag-DORwas detected by immunofluorescent staining. Scale
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Figure 5. The Beclin 2-GASP1 Interaction Is Essential for GPCR Degradation but Not Autophagy
(A) Coimmunoprecipitation of endogenous GASP1 in HEK293 cells transfected with indicated Flag epitope-tagged Beclin constructs.
(B) Alignment of amino acids 69–88 of Beclin 2 and Beclin 1 family members. Red arrow denotes position of Beclin 2 I80 residue.
(C) Coimmnoprecipitation of endogenous GASP1 in HEK293 cells transfected with indicated Flag epitope-tagged WT or mutant Beclin 2 constructs.
(D) Expression of Beclin 2 in HEK293 cells cotransfected with beclin 2 siRNA and indicated Beclin 2 NTm rescue plasmids.
(E) Effects of beclin 2 siRNA and indicated plasmid cotransfection on biotin-mediated protection of the DOR after agonist treatment (DADLE, 5 mM) in HEK293/
Flag-DOR cells.
(F) Quantification of the ratio of DOR levels at 180 min versus 30 min in each condition shown in (E). Bars represent mean ± SEM of three independent
experiments.
(G) Representative images of GFP-LC3 puncta in HeLa/GFP-LC3 cells after cotransfectionwith beclin 2 siRNA and indicated plasmid and culture for 3 hr in normal
or starvation medium. Arrows denote representative autophagosomes. Scale bar, 20 mm.
(H) Quantification of the GFP-LC3 puncta shown in (G). Bars represent mean ± SEM of triplicate samples (50 cells per sample). Similar results observed in three
independent experiments.
*p < 0.05; **p < 0.01; ***p < 0.001; NS, not significant; ANOVA with Dunnett method. See also Figure S5.
1094 Cell 154, 1085–1099, August 29, 2013 ª2013 Elsevier Inc.
D0
0.5
1.5
2.5
3.5
4.5
+/+ +/-
beclin 1
+/+ +/-
beclin 2
nitca/
R1
B
C
dezila
mro
N
4.0
3.0
2.0
1.0
*
NS
+/+ +/-
beclin 2
-/-
nitca/
R1
B
C
dezila
mro
N
*
G
CB1R
actin
+/+  +/-  -/-
beclin 2
 MEFs:
50 kD
37 kD
A
weanling
+/+ +/ - - / -
e16.5 -  18
e13.5 - 14
e8.5
47736
13 19 3
19 27 1
13 22 0
Age
beclin 2 genotype
C beclin 2
 MEFs:
starvation: -   +    -   +    -   +
+/+      +/-       -/-
p62
actin
LC3-I
LC3-II
50 kD
15 kD
10 kD
37 kD
B
  mouse
Beclin 2
actin
+/+  +/-   -/-
beclin 2
 MEFs:
50 kD
37 kD
E
0
2
4
6
8
12
10
14
18
16
Normal Starvation
**
*
0
2
4
6
8
12
10
14
*
Normal Starvation
eliforpllec/
P
A# 0
1
2
3
4
***
*
Normal Starvation
beclin 2 +/+
beclin 2 +/-
beclin 2- /  -
F
nietorp
devil-gnoL
)
%(
noitadarged
0
5
10
15
20
25
30 **
Normal 3 h starvation
*
*
beclin2+/+
beclin2+/ -
beclin2-/-
H
CB1R
1    2    3   4          1    2    3    4
actin
    Mouse
genotype:
1    2    3   4         1    2    3    4
50 kD
37 kD
beclin 2+/+ beclin 2+/ - beclin 1+/+ beclin 1+/-
eliforpllec/L
A#
eliforpllec/L
A+
P
A#
NS
NS
NS
NS
NS *
Figure 6. Role of Endogenous Mouse Beclin 2 in Autophagy and Regulation of CB1R Levels
(A) Genotype distribution of offspring from beclin 2+/ intercrosses at indicated ages.
(B) Western blot detection of Beclin 2 in MEFs of indicated genotype.
(C) Western blot detection of p62 and LC3 in MEFs of indicated genotype during growth in normal medium (starvation ‘‘-‘‘) or after 3 hr amino acid and serum
starvation (starvation ‘‘+’’). See Figure S6D for quantitative analysis of western blots from three independent experiments.
(D) Representative electronmicroscopic image of an autophagosome (arrow, upper panel) and an autolysosome (arrow, lower panel) in beclin 2+/+ MEFs cultured
for 3 hr in starvation medium. Scale bars, 500 nm.
(E) Electron microscopic quantification of autophagosomes (AP) and autolysosomes (AL) in MEFs of indicated genotype cultured for 3 hr in normal or starvation
medium. Results represent mean ± SEM of 25 random cell profiles per experimental group.
(F) Long-lived radiolabeled cellular protein degradation in MEFs of indicated genotype cultured for 3 hr in normal or starvation medium. Bars represent mean ±
SEM of three independent experiments.
(G) Western blot detection of CB1R in MEFs of indicated genotype. Quantification of normalized levels of CB1R is shown on right. Bars represent mean ± SEM of
three independent experiments.
For (E)–(G), *p < 0.05; **p < 0.01; ***p < 0.001; NS, not significant; ANOVA with Dunnett Method.
(H) Western blot detection of CB1R in whole-brain lysates from mice of indicated genotype. Quantification of normalized levels of CB1R is shown on right. Bars
represent mean ± SEM of four mice in each genotype. *p < 0.05; NS, not significant; ANOVA.
See also Figure S6.
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Figure 7. Beclin 2 Heterozygous Knockout Mice Develop Increased Body Weight and Insulin Resistance
(A) Weekly weights of 8-week-old littermatemice of indicated genotype during 8 weeks of RD or HFD treatment. p < 0.001 for beclin 2+/+ versus beclin 2+/ in both
RD and HFD conditions; linear mixed effect model.
(B) Daily food intake of littermate mice of indicated genotype at the end of 8 weeks of RD or HFD treatment. *p < 0.05; ANOVA.
(C and D) Glucose tolerance tests and insulin tolerance tests performed on littermate mice of indicated genotype after 8 weeks RD (C) or HFD (D) treatment.
p values in each graph represent the difference between two curves; see Experimental Procedures for details of statistical analysis.
For (A)–(D), results represent mean ± SEM for 6–8 mice per experimental group.
(E) Weight ratio changes of 8-week-old littermate mice of indicated genotypes fed with RD during 16 days of daily i.p. rimonabant (10 mg kg1) or vehicle control
treatment. Both genotypes had similar weight-ratio changes with rimonabant; p = NS; linear mixed effect model.
(F) Glucose tolerance tests on littermate mice of indicated genotypes fed with RD before and after 16 days of daily i.p. rimonabant treatment. *p < 0.05 for
comparison of glucose value between two groups at indicated time point; ANOVA.
For (E) and (F), results represent mean ± SEM for five mice per group.
See also Figure S7.proteins (e.g., Bcl-2, AMBRA1, and Rubicon) may underlie as-of-
yet undefined unique regulatory or functional features of Beclin 2
in autophagy. Perhaps differential mRNA stability or different
kinetics of gene expression of intronless human Beclin 2 versus
humanBeclin 1 (whichhasmultiple introns) contributes to tempo-
ral and/or spatial differences between the function ofBeclin 2 and1096 Cell 154, 1085–1099, August 29, 2013 ª2013 Elsevier Inc.Beclin 1 in autophagy induction in response to different stimuli
and indifferent cell typesor tissues. Similarly, the restricted tissue
pattern of expression of Beclin 2 versus Beclin 1 (which is
expressed ubiquitously) may reflect different roles of different
Beclin family members in autophagy regulation in different
tissues. The binding patterns of Beclin 2 suggest that, unlike
Beclin 1, it may not need to be ‘‘unleashed’’ from negative regu-
lators; during basal conditions in HeLa cells, we could not detect
any binding of Beclin 2 to the negative regulator, Rubicon, andwe
detected a marked increase in binding to the positive regulator,
AMBRA1. Moreover, unlike with Beclin 1, starvation-induced
autophagy does not appear to require disruption of the Bcl-2/
Beclin 2 complex; we speculate that this may be due to lack of
conservation in Beclin 2 of the T119 site in Beclin 1 that is phos-
phorylated by DAPK to promote disruption of Beclin 1 from bind-
ing to Bcl-2/Bcl-xL (Zalckvar et al., 2009). Furthermore, given the
findings that Bcl-2 sequesters AMBRA1 away from Beclin 1
(Strappazzon et al., 2011), the basal increase in AMBRA1 interac-
tion with Beclin 2 may bypass the need for Bcl-2/Bcl-xL to disso-
ciate from Beclin 2 during autophagy induction. Future studies
addressing the molecular regulation of Beclin 2 may unravel
previously unappreciated levels of complexity in the regulation
of Atg6/Beclin family members in autophagy.
Althoughmechanistically distinct, thedual functions ofBeclin 2
in GPCR degradation and autophagy may result in hitherto
unknown crosstalk between the two pathways. It is possible
that agonists of GASP1-dependent GPCRs (which trigger their
endolysosomal trafficking and degradation) ‘‘divert’’ Beclin 2
from an autophagy pathway to a GPCR degradation pathway.
Conversely, it is possible that GPCR agonists might upregulate
Beclin 2 expression, providing a larger pool of Beclin 2 to act
in autophagy. It is noteworthy that cannabinoids, agonists of
the CB1R, and morphine, an opioid receptor agonist, induce
autophagy (Salazar et al., 2009; Zhao et al., 2010). Although a
variety of mechanisms for these actions of cannabinoid and
opiate-induced autophagy have been proposed, including acti-
vation of endoplasmic reticulum stress, reactive oxygen species
generation, and the upregulation of Beclin 1 expression, the pre-
cise mechanisms by which CB1R and DOR agonists induce
autophagy are not completely understood. Beclin 2, which func-
tions in agonist-induced degradation of CB1Rs and DORs, may
also function in GPCR agonist-induced autophagy regulation.
More broadly, the dual function of Beclin 2 in mammalian
GPCR degradation and autophagy may reflect a need for higher
eukaryotes to tightly coordinate these different facets of the
cellular response to environmental cues. Interestingly, themajor-
ity of mammalian GPCRs are expressed in the brain and modu-
late neuronal function (Gainetdinov et al., 2004), and Beclin 2 has
high expression in mouse and human brain (Figures 1C and
S6C). In addition, although the DOR, CB1R, and b-adrenergic
receptor have exons, the majority of mammalian GPCRs are
intronless, and GPCRs constitute the majority of mammalian
intronless genes (Gentles and Karlin, 1999). The evolutionary
basis for the selection of this gene structure for mammalian
GPCRs remains unclear, but similar factors may have resulted
in the coevolution of human Beclin 2 (a protein involved in
GPCR regulation), which is also intronless. Aside from this paral-
lelism in the evolution of mammalian GPCR gene structure and
human Beclin 2 gene structure, the use of an Atg6/Beclin auto-
phagy gene homolog in the endolyososomal trafficking and
degradation of central nervous system (CNS)-expressed GPCRs
suggests an evolutionary advantage to coupling two distinct
trafficking functions (endolysosomal degradation of GPCRs
and autophagy) in the same protein.Our discovery of a role for Beclin 2 in the degradation of
GASP1-regulated GPCRs represents a mechanistic advance in
understanding agonist-induced GPCR degradation. GASP1,
originally identified in a yeast two-hybrid screen with the C termi-
nus of the DOR (Whistler et al., 2002), is expressed predomi-
nantly in the CNS (similar to Beclin 2) (Abu-Helo and Simonin,
2010; Simonin et al., 2004) and modulates the postendocytic
sorting of a highly specific subset of GPCRs to the lysosome
for degradation in a ubiquitin-independent manner (Moser
et al., 2010). This targeting of GPCRs to the degradative/lyso-
somal pathway has been shown to regulate virally encoded
GPCR signaling in vitro (Tschische et al., 2010), andmanipulation
of GASP1 function in vivo regulates pharmacological responses
to cannabinoids (agonists of CB1R) and cocaine (an indirect
agonist of the dopamine D2 receptor) (Moser et al., 2010).
Thus, GASP1-dependent sorting likely plays a key physiological
role in the regulation of signaling pathways mediated by GASP1-
interacting GPCRs. However, aside from its well-described high-
affinity interactions with cytoplasmic tails of multiple GPCRs
(Heydorn et al., 2004), little is known about the molecular mech-
anisms of GASP1 function, including its site of action in the endo-
cytic pathway and the identity of sorting machinery or other
proteins with which it may interact. The discovery of Beclin 2
as a GASP1-binding partner provides insights into the mecha-
nisms by which GASP1-regulated GPCRs are fated for endoly-
sosomal degradation.
We speculate that the function of Beclin 2 in GPCR degrada-
tion, like that of GASP1, may be important in regulating canna-
binoid receptor signaling. Among the three types of known
cannabinoid receptors found in mammals (CB1R, CB2R,
CB3R) (Maccarrone et al., 2010), CB1R is the major receptor in
the brain involved in the regulation of food intake and energy
balance. It can be induced by the exogenous administration of
cannabinoids, which are the active ingredient ofCannabis sativa,
as well as by endocannabinoids, a family of polyunsaturated
lipids endogenously synthesized as natural ligands of the
CB1R. CB1R activation by these exogenous or endogenous
agonists leads to increased appetite, increased food intake,
and an obesity/diabetes phenotype (Maccarrone et al., 2010),
whereas CB1R knockout mice are lean with reduced food intake
(Cota et al., 2003). Moreover, CB1R antagonists, such as rimo-
nabant, reduce body weight and insulin resistance in both obese
rodents and humans (Di Marzo, 2008). In our study, we noted
that beclin 2 heterozygous-deficient mice have elevated levels
of brain CB1R expression, increased body weight, increased
food intake, and insulin resistance. These phenotypes are highly
consistent with increased CB1R signaling; yet, we cannot defin-
itively conclude that there is a causal relationship between the
elevated levels of CNS CB1R expression and the physiological
abnormalities we noted in the beclin 2 heterozygous-deficient
mice, as other functions of beclin 2 may contribute to these
abnormalities. However, it is unlikely that they are related to
decreased autophagy, as we found that beclin 1 heterozy-
gous-deficient mice did not have increased CNS expression of
CB1R, increased body weight, increased food intake, or insulin
resistance. Further investigations are warranted to determine
whether mouse beclin 2 allelic loss alters other GASP1-depen-
dent GPCR signaling functions in vivo.Cell 154, 1085–1099, August 29, 2013 ª2013 Elsevier Inc. 1097
Interestingly, chromosome 1q43, the genetic locus that
contains human beclin 2, has been linked to obesity and dia-
betes-related traits inmultiple ethnic populations, including Cau-
casians, Mexican Americans, Pacific Islanders, and Caribbean
Hispanics (Aissani et al., 2006; Bosse´ et al., 2004; Dong et al.,
2011; Schelling et al., 2008; Shmulewitz et al., 2006). Additional
genetic studies are needed to determine whether beclin 2 is a
bona fide risk allele for obesity and diabetes in humans. Our find-
ings that beclin 2 heterozygous-deficient mice have increased
body weight and insulin resistance provide a strong rationale
for such studies; Beclin 2 may represent a newly identified regu-
lator of body weight and glucose homeostasis not only in mice
but also in humans.
EXPERIMENTAL PROCEDURES
Cell Culture
HEK293 cell lines stably expressing Flag epitope-tagged GPCRs have been
previously described (Martini et al., 2007; Whistler et al., 2002). Primary
MEFs were isolated from offspring at embryonic day (E) 13.5 of autophagy
mutant mice (described in Extended Experimental Procedures). HEK293,
HeLa, mouse Neuro2A, and CCD-1064Sk cell lines were obtained from
ATCC (American Type Culture Collection). HeLa/GFP-LC3 cells were previ-
ously described (Orvedahl et al., 2010).
Yeast Two-Hybrid Screen
The yeast two-hybrid screen of human Beclin 2 N-terminal region (amino acids
1–88) binding partners was performed with the Matchmaker Gold Yeast Two-
Hybrid System (Clontech). The bait GAL4 Beclin 2-BD fusion was cloned into
pGBKT7 and transformed into the yeast strain Y187 containing the Mate &
Plate Library of human brain cDNAs (Clontech), according to the manufac-
turer’s instructions.
Coimmunoprecipitation
Cells were lysed in lysis buffer and subjected to immunoprecipitation with
anti-Flag antibody, anti-Myc antibody, anti-Beclin 2 antibody, or anti-Beclin 1
antibody. Eluates were separated by SDS-PAGE and detected by western blot
analyses. For details of conditions and antibodies used, see Extended Exper-
imental Procedures.
Biotin Protection Degradation Assay
The biotin protection degradation assay was performed on HEK293 cells sta-
bly expressing Flag epitope-tagged receptors with a modification of the
method previously described (Whistler et al., 2002). See Extended Experi-
mental Procedures for details.
Receptor Internalization and Recycling Assay
Theantibody-feeding immunofluorescenceDORrecyclingassaywasperformed
as described in detail in Extended Experimental Procedures, with 140 min
agonist (5 mM DADLE) and 30 min antagonist (10 mM naloxone) treatment.
Autophagy Assays
Autophagy was measured by LC3 and p62 western blotting, quantitative elec-
tron microscopy, measurement of long-lived protein degradation, and quanti-
tation of GFP-LC3 puncta in HeLa/GFP-LC3 cells. For details, see Extended
Experimental Procedures.
Contruction of Beclin 2 Knockout Mice
The targeting construct with the beclin 2 coding region replaced by a neomycin
marker flanked by LoxP sites was electroporated into embryonic stem cells
(ESCs). The knockout clones were screened and injected into donor blasto-
cysts, and offspring with germline transmission were bred to mice expressing
Cre from the CAG promoter to remove the neomycin cassette. For detailed
methods, see Extended Experimental Procedures.1098 Cell 154, 1085–1099, August 29, 2013 ª2013 Elsevier Inc.Animal Experiments
MaleC57BL/6Jmice (beclin 2+/, beclin 1+/, andWT littermates) were housed
on a 12 hr light/dark cycle. They were fed either with a RD (Harlan Teklad) or a
HFD containing 60% fat (Research Diets, D12492). Rimonabant (Cayman
Chemical) was administered intraperitoneally (i.p.) in phosphate-buffered
saline (PBS) with 0.3% Tween 80 (10 mg kg1 body weight daily). All animal
protocols were approved by the UTSW Medical Center Institutional Animal
Care and Use Committee.
Mouse Metabolic Studies and Blood Tests
Food intake and physical activity were measured in TSE metabolic chambers
(TSE Systems) over a 5 day period. Glucose tolerance tests were performed
by i.p. glucose injection (1 g kg1) after a 3 hr fast. Insulin tolerance tests were
performed by i.p. insulin (Novo Nordisk and Sigma) injection (0.8 unit kg1)
after a 3 hr fast. Blood was drawn from tail veins at the indicated time
points after glucose or insulin injection, and serum glucose levels were
analyzed using commercial glucose assay reagents (Sigma, Cat# 6918,
P7119, F5803).
Statistical Analyses
For comparisons of the means of two groups, one-way ANOVA was used. For
comparison of multiple groups with a control group, ANOVA with the Dunnet
method was used. Linear mixed effect models (which compare differences
between groups, while accounting for correlations within the same subject)
were used to compare different changes for slopes of linear curves among
groups. To determine the difference between nonlinear curves in two groups,
analyses were performed using the statistical modeling package statmod,
which is available from the R Project for Statistical Computing (http://www.
r-project.org).
ACCESSION NUMBERS
The human beclin 2 and mouse beclin 2 sequences were deposited in the
NCBI database with GenBank accession numbers HM03116 and KF511582,
respectively.
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